Alex H. Chang

3.3k total citations
70 papers, 1.8k citations indexed

About

Alex H. Chang is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Alex H. Chang has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 20 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Alex H. Chang's work include CAR-T cell therapy research (46 papers), Virus-based gene therapy research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Alex H. Chang is often cited by papers focused on CAR-T cell therapy research (46 papers), Virus-based gene therapy research (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Alex H. Chang collaborates with scholars based in China, United States and Canada. Alex H. Chang's co-authors include Michel Sadelain, Matthias T. Stephan, Glenn Heller, Vladimir Ponomarev, Konstantin Dobrenkov, Renier J. Brentjens, Biping Deng, He Huang, Yongxian Hu and Jing Pan and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alex H. Chang

65 papers receiving 1.7k citations

Peers

Alex H. Chang
Siok‐Keen Tey Australia
David T. Rodgers United Kingdom
Christopher Bebbington United States
Kathryn Leung United States
Chongyun Fang United States
Zacarias Garcia France
Lianjun Shen China
Robin Parihar United States
Joyce Chen United States
Shannon E. McGettigan United States
Siok‐Keen Tey Australia
Alex H. Chang
Citations per year, relative to Alex H. Chang Alex H. Chang (= 1×) peers Siok‐Keen Tey

Countries citing papers authored by Alex H. Chang

Since Specialization
Citations

This map shows the geographic impact of Alex H. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex H. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex H. Chang more than expected).

Fields of papers citing papers by Alex H. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex H. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex H. Chang. The network helps show where Alex H. Chang may publish in the future.

Co-authorship network of co-authors of Alex H. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Alex H. Chang. A scholar is included among the top collaborators of Alex H. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex H. Chang. Alex H. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Sapana R., et al.. (2025). DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) Is More: A Rare Case of Acalculous Cholecystitis. ACG Case Reports Journal. 12(12). e01921–e01921.
2.
Yang, Tingting, Yetian Dong, Mingming Zhang, et al.. (2024). Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 2818–2818. 1 indexed citations
3.
Sperger, Jamie M., Marina N. Sharifi, V. Carreño, et al.. (2024). Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancer. Cancer Research. 84(6_Supplement). 3696–3696.
4.
Deng, Biping, Zhaoli Liu, Xiaoming Qu, et al.. (2024). Different T-Cell Activation Approaches Impact the Resulting CART-Cell Products and Possible Clinical Outcomes. Blood. 144(Supplement 1). 4856–4856. 2 indexed citations
5.
Zhang, Yinqiang, Chenggong Li, Mengyi Du, et al.. (2023). Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer Journal. 13(1). 61–61. 52 indexed citations
6.
Tan, Yue, Liping Zhao, Biping Deng, et al.. (2023). Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia. Journal of Hematology & Oncology. 16(1). 34–34. 49 indexed citations
7.
8.
Hu, Yongxian, Fang Ni, Zhongli Yang, et al.. (2022). CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nature Communications. 13(1). 5313–5313. 90 indexed citations
9.
Wei, Guoqing, Yanlei Zhang, Houli Zhao, et al.. (2021). CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study. Cancer Immunology Research. 9(9). 1061–1070. 47 indexed citations
10.
Shao, Mi, Qin Yu, Xinyi Teng, et al.. (2021). CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial. Bone Marrow Transplantation. 56(7). 1642–1650. 24 indexed citations
11.
Zeng, Baozhen, Zhen Li, Qiaofen Fu, et al.. (2021). CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma. Frontiers in Oncology. 10. 607362–607362. 10 indexed citations
12.
Deng, Biping, Jing Pan, Zhaoli Liu, et al.. (2021). Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL. Molecular Therapy — Methods & Clinical Development. 23. 633–643. 10 indexed citations
13.
Zhang, Hao, Yongxian Hu, Alex H. Chang, & He Huang. (2020). Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib. Regenerative Therapy. 14. 40–42. 5 indexed citations
14.
Jin, Aiyun, Jingjing Feng, Guoqing Wei, et al.. (2020). CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations. Bone Marrow Transplantation. 55(4). 717–721. 7 indexed citations
15.
Xu, Qing, Jingyun Shi, Yuqing Sun, et al.. (2013). Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models. Clinical & Translational Oncology. 16(4). 395–401. 5 indexed citations
16.
Pepperell, Caitlin S., Alex H. Chang, Wendy Wobeser, Julie Parsonnet, & Vernon Hoeppner. (2011). Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities. The International Journal of Tuberculosis and Lung Disease. 15(7). 899–905. 7 indexed citations
17.
Stephan, Matthias T., Vladimir Ponomarev, Renier J. Brentjens, et al.. (2007). T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine. 13(12). 1440–1449. 237 indexed citations
18.
Chang, Alex H., Matthias T. Stephan, & Michel Sadelain. (2006). Stem cell–derived erythroid cells mediate long-term systemic protein delivery. Nature Biotechnology. 24(8). 1017–1021. 62 indexed citations
19.
Chang, Alex H.. (2003). cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Molecular Brain Research. 116(1-2). 27–37. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siok‐Keen Tey Breakdown of academic impact, for papers by David T. Rodgers Breakdown of academic impact, for papers by Christopher Bebbington Breakdown of academic impact, for papers by Kathryn Leung Breakdown of academic impact, for papers by Chongyun Fang Breakdown of academic impact, for papers by Zacarias Garcia Breakdown of academic impact, for papers by Lianjun Shen Breakdown of academic impact, for papers by Robin Parihar Breakdown of academic impact, for papers by Joyce Chen Breakdown of academic impact, for papers by Shannon E. McGettigan
Rankless by CCL
2026